Delivery Order SPE2DB20D3101-SPE2DB24FQTF2
- Not listed
- This federal contract award, valued at $9,445.84, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is for the delivery of 4565684035 - PIRFENIDONE 801 MG TABLET 90S, a pharmaceutical product, with a completion date of September 5, 2024. The contract is a Delivery Order on a Firm Fixed Price basis and does not have a set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, will be the prime contractor responsible for...
- This federal contract award, with ID SPE2DB22D3019|SPE2DB24FK3AQ, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distribution and healthcare solutions provider. The $10,677.83 firm-fixed-price delivery order is for 4563775122 - PIRFENIDONE 801 MG TABLET 90S, with a completion date of February 27, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $38,353.62 firm fixed-price delivery order is for the supply of 4560843693 PIRFENIDONE 801 MG TABLET 90S. The contract has an ultimate completion date of May 8, 2023. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,452.41 firm fixed-price delivery order is for the supply of 4562731597 - PIRFENIDONE 267 MG TABLET 270S, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) between the DLA and Cencora, Inc., valued up to $999,999,999.00, which serves as the primary vehicle for Amerisourcebergen to provide a...
- This is a federal contract award made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $6,699.45, is for the delivery of Pirfenidone 267 mg Capsules in quantities of 270. The award is a delivery order under the company's larger Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $17,354.64, is for the delivery of PIRFENIDONE 267 MG TABLET 270S, a pharmaceutical product. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) between the DLA and Cencora, Inc., valued at up to $999,999,999.00 and running through November 2026. The IDC serves as the primary vehicle...
- This federal contract award is for the delivery of Pirfenidone 801 mg tablets to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on March 30, 2023, with a ceiling value of $14,463.41 and an ultimate completion date of March 31, 2023. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a...
- This is a federal contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,495.10, is for the delivery of 270 capsules of the medication Pirfenidone 267 mg. The contract has an ultimate completion date of January 23, 2024 and is a Firm Fixed Price Delivery Order. There is no set-aside designation for this contract. AmerisourceBergen Drug Corp is the...
- This federal contract award, valued at $3,433.03, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of PIRFENIDONE 267 MG TABLET 90S, a pharmaceutical product, with a performance period ending on February 6, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This federal contract award, valued at $9,653.84, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of PIRFENIDONE 801 MG TABLET 90S, a pharmaceutical product, to support military healthcare programs. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB24FQTF2Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $21,646.99 firm fixed-price delivery order is for the supply of 4562569509 ! PIRFENIDONE 267 MG CAPSULE 270S, a pharmaceutical product. The contract has an ultimate completion date of October 24, 2023 and was awarded on October 23, 2023. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies, particularly within military and veterans' healthcare systems. The company holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.6k | 10/23/23 |